Laserfiche WebLink
submitted with the progress reports <br />An original plus two copies of the reports must be mailed to the GMS for approval by the GMO by the due date <br />noted. Ensure the Award and Program Announcement numbers shown above are on the reports. <br />The final and other programmatic reports required by the terms and conditions of the NoA are the following. <br />Final Performance Report: An original and two copies are required. At a minimum, the report should include <br />the following: <br />• Statement of progress made toward the achievement of originally stated aims. <br />• Description of results (positive or negative) considered significant. <br />• List of publications resulting from the project, with plans, if any, for further publication. <br />Final Federal Financial Report (FFR, SF -425): The FFR should only include those funds authorized and <br />actually expended during the timeframe covered by the report. The Final FFR, SF -425 is required and must be <br />submitted to the GMO/GMS no later than 90 days after the end of the project period. This report must indicate the <br />exact balance of unobligated funds and may not reflect any unliquidated obligations. Should the amount not <br />match with the final expenditures reported to the Department of Health and Human Services' Payment <br />Management Services (PMS), you will be required to update your reports to PMS accordingly. Remaining <br />unobligated funds will be de -obligated and returned to the U.S. Treasury. <br />If the final reports (FFR and Final Progress Report) cannot be submitted within 90 days after the end of the <br />project period, in accordance with 45 CFR Part 75.381 (Closeout), the grantee must submit a letter requesting an <br />extension that includes the justification for the delay and state the expected date the CDC Office of Grants <br />Services will receive the reports. All required documents must be mailed to the business contact identified in Staff <br />Contacts. <br />Equipment Inventory Report: An original and two copies of a complete inventory must be submitted for all <br />major equipment acquired or furnished under this project with a unit acquisition cost of $5,000 or more. The <br />inventory list must include the description of the item, manufacturer serial and/or identification number, acquisition <br />date and cost, percentage of Federal funds used in the acquisition of the item. The grantee should also identify <br />each item of equipment that it wishes to retain for continued use in accordance with 45 CFR Part 75. These <br />requirements do apply to equipment purchased with non-federal funds for this program. The awarding agency <br />may exercise Its rights to require the transfer of equipment purchased under the assistance award referenced in <br />the cover letter. CDC will notify the grantee if transfer to title will be required and provide disposition instruction on <br />all major equipment. Equipment with a unit acquisition cost of less than $5,000 that is no longer to be used in <br />projects or programs currently or previously sponsored by the Federal Government may be retained, sold, or <br />otherwise disposed of, with no further obligation to the Federal Government. If no equipment was acquired under <br />this award, a negative report is required. <br />Final Invention Statement: An original and two copies of a Final Invention Statement are required. Electronic <br />versions of the form can be downloaded by visiting httr)://grantsl .nih..qoy/grants/hhs568.pdf. If no <br />inventions were conceived under this assistance award, a negative report is required. This statement may be <br />included in a cover letter. <br />CQCA, Ot S AND, RESPON$I�I ITI S <br />Roles and Responsibilities: Grants Management Specialists/Officers (GMO/GMS) and Program/Project Officers <br />(PO) work together to award and manage CDC grants and cooperative agreements. From the pre -planning stage <br />to closeout of an award, grants management and program staff have specific roles and responsibilities for each <br />phase of the grant cycle. The GMS/GMO is responsible for the business management and administrative <br />functions. The PO is responsible for the programmatic, scientific, and/or technical aspects. The purpose of this <br />factsheet is to distinguish between the roles and responsibilities of the GMO/GMS and the PO to provide a <br />description of their respective duties. <br />Grants Management Officer: The GMO is the federal official responsible for the business and other non - <br />programmatic aspects of grant awards including: <br />